Table 2.
Study | Published time | Country | Study design | Patients | Age | Gender (male) | NOS grade |
---|---|---|---|---|---|---|---|
Cataldo, M. A et al. [3] | 2020 | Italy | Cohort study | 57 | 62 ± 13 | 41/16 | 7 |
Garcia, Pedro David Wendel et al. [24] | 2020 | European | Cohort study | 639 | 63 (53–71) | 480/159 | 8 |
Zhang, H. et al. [25] | 2020 | CHN | Cohort study | 38 | 64.76 ± 13.76 | 32/6 | 7 |
Massart, N. et al. [10] | 2021 | France, Switzerland, Belgium | Cohort study | 4010 | NR | NR | 8 |
Palanisamy, N. et al. [16] | 2021 | India | Cohort study | 750 | 60 ± 17.71 | 562/188 | 8 |
Bartoszewicz, M. et al. [13] | 2023 | Poland | Cohort study | 201 | 66.1 ± 12.1 | 114/87 | 8 |
Dupper, A. C. et al. [19] | 2022 | US | Case-control study | 96 | 64.91 ± 9.51 | 57/39 | 8 |
NOS Newcastle-Ottawa Scale, NR Not reported